СюжетСтоимость нефти:
Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
。关于这个话题，搜狗输入法2026提供了深入分析
view = result.value; // Must reassign
Что думаешь? Оцени!
This Tweet is currently unavailable. It might be loading or has been removed.